PTGX May 2024 25.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:31PM EDT. Market open.
| Previous close | 0.55 |
| Open | 6.00 |
| Bid | 4.60 |
| Ask | 8.00 |
| Strike | 25.00 |
| Expiry date | 2024-05-17 |
| Day's range | 6.00 - 6.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 4 |
GuruFocus.comProtagonist Therapeutics Inc (PTGX) Surpasses Q1 Revenue Estimates with Strategic Collaborations
Comprehensive Analysis of Q1 2024 Earnings and Strategic Developments
Simply Wall St.We Might See A Profit From Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Soon
With the business potentially at an important milestone, we thought we'd take a closer look at Protagonist...
GlobeNewswireTurnstone Biologics Appoints William Waddill to its Board of Directors
SAN DIEGO, April 16, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy, today announced the appointment of industry veteran William Waddill to the Company’s Board of Directors. The Company also announced that Patrick Machado has stepped down as a member o
© 2024 Yahoo. All rights reserved.